Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 82 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 01/20/22
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 03/23/22
End: 03/20/24
Due: 03/20/25
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/07/22
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 02/15/23
End: 12/31/24
Due: 12/31/25
A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors
Phase: N/A
Priority: Normal
Start: 02/07/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 03/20/25
End: 03/30/27
Due: 03/30/28
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 05/08/24
End: 12/30/29
Due: 12/30/30
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 05/31/20
Due: 05/31/21
Phase: N/A
Priority: Normal
Start: 02/23/21
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 12/19/16
End: 01/28/19
Due: 01/28/20
Phase: N/A
Priority: Normal
Start: 02/16/23
End: 02/28/27
Due: 02/28/28
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 10/21/21
End: 03/10/23
Due: 03/10/24
Phase: N/A
Priority: Normal
Start: 09/08/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 08/10/22
End: 12/25/24
Due: 12/25/25
Phase: N/A
Priority: Normal
Start: 09/15/21
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/16/22
End: 07/01/24
Due: 07/01/25